MultiFluor Western Blotting products.

An operation to eliminate pancreatic tumors may be the best opportunity for survival a individual can be provided, but most individuals are not operable due to the complexity, size and location of the tumor. The Phase I/IIa medical trial included nine individuals that all received four dosages of BC-819, weekly for 14 days twice, in america at the University of Maryland INFIRMARY, MD, and in Israel at Hadassah, Sheba, Hillel and Meir Yafe Medical Centers. Three individuals received the lower dosage , while six others received the bigger dose . Outcomes of pre-clinical testing shows that in pets treated with the sequence of BC-819 and Gemzar, the quantity of tumors shrank considerably, in comparison to the pets treated with Gemzar only.